FDA Brief

Warning letters Drugs

FDA warning letter to

Ray’s Vitamins

High riskIssued Apr 24Posted May 5Center for Drug Evaluation and Research (CDER)

FDA says Ray's Vitamins sells "Yeicob Ácido Hialurónico" as a supplement, but it is an unapproved, misbranded drug containing hidden diclofenac and dexamethasone.

What happened

FDA reviewed the website raysvitamins.com in April 2026 and also bought a sample of "Yeicob Ácido Hialurónico" through that website. Laboratory analysis found the product contains diclofenac (an anti-inflammatory pain drug) and dexamethasone (a steroid), neither listed on the label. The website also sells "RM Joe" and "RMSOL GRACIAN," which FDA has not sampled but says similarly named products have contained undeclared drug ingredients.

What FDA found

  1. The product is a new drug sold without an FDA-approved application.

    Section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  2. The label does not disclose that the product contains diclofenac and dexamethasone, which makes it misbranded.

    Section 502(a) of the FD&C Act, 21 U.S.C. 352(a)
  3. It cannot be a dietary supplement because diclofenac and dexamethasone were approved as drugs before they were ever sold as food or supplements.

    Section 201(ff)(3)(B)(i) of the FD&C Act, 21 U.S.C. 321(ff)(3)(B)(i)
  4. Website claims about arthritis, joint and muscle pain show the product is intended to treat disease, which makes it a drug.

    Section 201(g)(1)(B) of the FD&C Act, 21 U.S.C. 321(g)(1)(B)
  5. FDA is also concerned about "RM Joe" and "RMSOL GRACIAN" sold on the site, since similarly named products have contained undeclared drug ingredients.

What FDA wants

FDA asks the company to write back within fifteen working days describing the specific steps taken to fix the violations and prevent them from recurring, with supporting documents, or to explain why it believes the products are compliant.

Who should pay attention

  • online retailers selling imported joint-pain or arthritis supplements
  • distributors and stores carrying Latin American supplement brands
  • firms selling products named RM Joe or RMSOL GRACIAN

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk